Latest / Rhythm of Life / The Promise, The Risk, And The Future Of Healing Ep. 38
Transcript
- 0:00[SPEAKER_01]: What if healing is not always about suppressing a symptom?
- 0:03[SPEAKER_01]: What if under the right conditions, it is about seeing the source of our pain differently and creating enough space in the mind to choose a new response.
- 0:11[SPEAKER_01]: For decades, psychedelic medicines were pushed to the edges of American culture, associated with counter culture, criminalized, and largely removed from mainstream research.
- 0:22[SPEAKER_01]: Today that picture is changing, scientists, therapists, veterans, patients, and advocates are asking whether substances such as psilocybin, mdma, ketamine, and ibegane might help people living with depression, addiction, trauma, and end of life anxiety.
- 0:41[SPEAKER_01]: The early findings are promising.
- 0:43[SPEAKER_01]: But the story is not simple.
- 0:45[SPEAKER_01]: These substances can carry serious psychological, medical, legal, and ethical risks.
- 0:52[SPEAKER_01]: They are not shortcuts, and they did not suddenly appear when Western science became interested in them.
- 0:58[SPEAKER_01]: I recently sat down with Lisa Solomon for an in-depth conversation about psychedelic medicine.
- 1:03[SPEAKER_01]: That interview covered in enormous amount of ground.
- 1:06[SPEAKER_01]: So I wanted a step back, examine the larger picture, and share some of the most important ideas I took away from it.
- 1:13[SPEAKER_01]: This is not a condensed version of our interview.
- 1:16[SPEAKER_01]: It is a companion piece, an opportunity to place Lisa's insights within the broader questions surrounding the science, promise, risks, and future of psychedelic therapy.
- 1:27[SPEAKER_01]: If this subject interests you, I encourage you to watch our full conversation as well.
- 1:33[SPEAKER_01]: Before discussing clinical trials or brain science, Lisa wanted to begin with acknowledgement.
- 1:39[SPEAKER_01]: Many plant medicines now being studied or commercialized have been stewarded by indigenous peoples for generations, sometimes for centuries, in healing ceremonies, spiritual practice, and rights of passage.
- 1:54[SPEAKER_01]: Their knowledge survived colonization, prohibition, and cultural erasure.
- 1:59[SPEAKER_01]: That history matters.
- 2:02[SPEAKER_01]: As Lisa explained, if it were not for indigenous communities and their ceremonies, we might not know about many of these medicines.
- 2:10[SPEAKER_01]: Their traditions need to be honored and respected.
- 2:14[SPEAKER_01]: That also means recognizing that some of these plants are not infinitely abundant, and considering how the communities that preserve this knowledge can be supported and compensated.
- 2:24[SPEAKER_01]: That distinction between a medicine and a commodity,
- 2:28[SPEAKER_01]: and a medicine held within a culture runs through this entire conversation.
- 2:33[SPEAKER_01]: In a traditional setting, the substance may be only part of the experience.
- 2:38[SPEAKER_01]: There may also be ritual, music, relationship, shared belief, community, and a trained guide whose knowledge has been passed down across generations.
- 2:49[SPEAKER_01]: A Western clinic may offer medical screening, measured dosing, and controlled conditions.
- 2:55[SPEAKER_01]: Each model holds something valuable, and neither should casually claim authority over the other.
- 3:01[SPEAKER_01]: So what do we mean by psychedelic?
- 3:03[SPEAKER_01]: The term cover substances that can alter perception, mood, and a person's sense of self or meaning.
- 3:10[SPEAKER_01]: Classics psychedelics such as psilocybin and LSD act primarily through serotonin-related systems.
- 3:17[SPEAKER_01]: MDMA is often described as an intactogen or empathogen because it may increase feelings of openness and connection.
- 3:27[SPEAKER_01]: Ketamine is technically a dissociative anesthetic, but it is frequently included in this conversation because it can produce profound shifts in perception and is already used in some psychiatric care.
- 3:39[SPEAKER_01]: But many psychedelic therapies share one compelling idea.
- 3:44[SPEAKER_01]: under carefully supported conditions, and altered state may allow a person to relate differently to thoughts, memories, and deeply established patterns.
- 3:54[SPEAKER_01]: Lisa described this as stepping outside the usual story.
- 3:58[SPEAKER_01]: Some of these medicines appear to open a window of nearer plasticity, a period when it may be easier to reshape behaviors and thought patterns.
- 4:06[SPEAKER_01]: They may also interrupt the repetitive mental loops people get stuck in.
- 4:11[SPEAKER_01]: The same reaction, the same self-criticism, and the same belief about who they are.
- 4:16[SPEAKER_01]: Think of a path through a field.
- 4:18[SPEAKER_01]: Walk at once in the grass, springs back.
- 4:21[SPEAKER_01]: Walk it every day for 20 years, and it becomes a deep trail.
- 4:25[SPEAKER_01]: Trauma, depression, and addiction can create patterns that feel just as fixed.
- 4:30[SPEAKER_01]: A psychedelic experience may briefly reveal that the trail is not the whole field.
- 4:35[SPEAKER_01]: But seeing another path is not the same as building a life upon it.
- 4:39[SPEAKER_01]: That is why people working in this field so often return to three words.
- 4:45[SPEAKER_01]: Preparation, experience, and integration.
- 4:49[SPEAKER_01]: Preparation begins before any medicine is taken.
- 4:52[SPEAKER_01]: It can include medical and psychiatric screening, a review of prescriptions and supplements,
- 4:59[SPEAKER_01]: and honest discussion of risks and a conversation about expectations and intentions.
- 5:04[SPEAKER_01]: It also means who will be present, what their training is, what boundaries are in place, and what happens if there is an emergency.
- 5:13[SPEAKER_01]: The experience itself is shaped by what researchers call set and setting.
- 5:18[SPEAKER_01]: The person's mindset, the physical environment, the people present, and the emotional tones surrounding the session.
- 5:25[SPEAKER_01]: These factors do not make a dangerous substance
- 5:29[SPEAKER_01]: But they can have a powerful effect on how an experience unfolds.
- 5:33[SPEAKER_01]: Then comes integration, the work of making meaning of what occurred, and translating insight into daily life.
- 5:40[SPEAKER_01]: One point Lisa returned to again and again was this.
- 5:43[SPEAKER_01]: The potential is not just in the medicine, and it is not just in the experience.
- 5:49[SPEAKER_01]: Someone may see a pattern differently, but what will the new pattern be?
- 5:54[SPEAKER_01]: How will it become part of everyday life?
- 5:56[SPEAKER_01]: That is where integration can be so important.
- 5:59[SPEAKER_01]: Imagine a person who has lived with addiction for years.
- 6:03[SPEAKER_01]: Even if a treatment reduces craving, that person may return to damaged relationships, old triggers, unemployment, isolation, or social world organized around substance abuse.
- 6:15[SPEAKER_01]: The absence of a craving does not automatically supply a home, a community, a purpose, or a repaired family.
- 6:24[SPEAKER_01]: Integration can involve psychotherapy, group support, changes in routine, creative practice, spiritual care, or rebuilding relationships.
- 6:34[SPEAKER_01]: It is less about explaining a vision than helping a person live differently after it.
- 6:39[SPEAKER_01]: Lisa spoke about combat veterans.
- 6:41[SPEAKER_01]: Some of whom carry not only fear and grief about what clinicians call moral injury, suffering connected to acts they committed, witnessed, or could not prevent and war.
- 6:52[SPEAKER_01]: A veteran may have spent years believing in
- 6:55[SPEAKER_01]: I am a terrible person because I caused harm.
- 6:57[SPEAKER_01]: In a supported therapeutic experience, that person may be able to step outside that single judgment and see the full context.
- 7:06[SPEAKER_01]: I was serving.
- 7:07[SPEAKER_01]: I was protecting the people of side me.
- 7:10[SPEAKER_01]: I was placed in an impossible situation.
- 7:13[SPEAKER_01]: The memory is not erased, but the person's relationship to it may change.
- 7:19[SPEAKER_01]: MDMA assisted therapy as drawn in particular interest for post-traumatic stress disorder.
- 7:24[SPEAKER_01]: MDMA may reduce fear and increase trust and emotional openness, potentially making it possible to approach traumatic memories without becoming overwhelmed, but MDMA is not currently a routine,
- 7:37[SPEAKER_01]: self-administer treatment for PTSD and illicit products sold as molly or ecstasy may contain unknown substances.
- 7:45[SPEAKER_01]: Silosibin, the psychoactive compound found in certain mushrooms, is being studied for depression, addiction, PTSD, and distress associated with serious illness.
- 7:56[SPEAKER_01]: One of the most striking possibilities is not simply that it may improve mood, but that some participants describe an enduring change in meaning.
- 8:05[SPEAKER_01]: greater connection, less fear, or a renewed sense that their life belongs to something larger than the isolated self.
- 8:12[SPEAKER_01]: The spiritual dimension deserves respect, without being confused with scientific proof.
- 8:18[SPEAKER_01]: A profound experience may be deeply healing.
- 8:21[SPEAKER_01]: But intensity alone does not guarantee truth, safety, or lasting benefit.
- 8:27[SPEAKER_01]: Then there is ketamine.
- 8:28[SPEAKER_01]: ketamine has been used for decades as an anesthetic in psychiatric care.
- 8:33[SPEAKER_01]: Clinicians may prescribe ketamine off-label while a related nasal medication, S ketamine, has FDA approval for certain forms of severe depression, and must be administered under medical supervision.
- 8:46[SPEAKER_01]: ketamine can act rapidly.
- 8:48[SPEAKER_01]: One reason it has become important in conversations about major depression and acute suicidal thinking.
- 8:54[SPEAKER_01]: Some patients describe a temporary loosening of despair or an experience of connection they had not felt in years, but rapid relief is not the same thing as a permanent cure.
- 9:06[SPEAKER_01]: ketamine can cause disassociation, sedation, increases in blood pressure, and problems associated with misuse.
- 9:13[SPEAKER_01]: Clinical supervision matters, and repeated treatment should be part of a thoughtful care plan, not an escape that becomes its own cycle.
- 9:22[SPEAKER_01]: I began maybe the clearest example of why hope must be paired with caution.
- 9:27[SPEAKER_01]: derived from the Iboga plant of Central Africa and rooted in wheat tea spiritual traditions, I began his attractive attention for possible effects on opioid withdrawal, craving, trauma, and addiction.
- 9:40[SPEAKER_01]: People have reported dramatic changes after single experience.
- 9:45[SPEAKER_01]: Veterans and former professional athletes have become vocal advocates.
- 9:49[SPEAKER_01]: Researchers are also investigating related compounds and modified molecules that might preserve therapeutic benefits while reducing risk.
- 9:58[SPEAKER_01]: That advocacy recently reached one of the largest podcast audiences in the world.
- 10:03[SPEAKER_01]: On April 1st, 2026,
- 10:05[SPEAKER_01]: Joe Rogan devoted more than two hours of the Joe Rogan experience to a conversation with former Texas governor and former U.S. Secretary of Energy Rick Perry with W. Brian Hubbard, the CEO of Americans for EyeBegain.
- 10:20[SPEAKER_01]: It was episode 2477 and it was actually their second appearance together on Rogan's show.
- 10:27[SPEAKER_01]: What made the conversation remarkable was the political ground it covered.
- 10:32[SPEAKER_01]: Perry comes from a deeply conservative background, not the part of the political spectrum traditionally associated with psychedelic medicine.
- 10:41[SPEAKER_01]: Yet he has become a forceful advocate for studying eye-be-gain, particularly for veterans living with trauma and people fighting opioid addiction.
- 10:50[SPEAKER_01]: Hubbard laid out the case for moving Ibogaine into rigorous American research, not treating personal testimony as final proof, but taking those reports seriously enough to conduct properly funded clinical trials.
- 11:04[SPEAKER_01]: Whatever you think of Joe Rogan or Rick Perry politically, that conversation demonstrated how dramatically this issue has crossed old cultural boundaries.
- 11:14[SPEAKER_01]: Psychedelic medicine is no longer a discussion confined to the counterculture.
- 11:19[SPEAKER_01]: It now includes veterans, conservative lawmakers, scientists, physicians, addiction specialists, and families who believe conventional treatments have not been enough, but eye-begining can affect the heart's electrical rhythm and has been associated with fatal cardiac events.
- 11:37[SPEAKER_01]: Liver function, electrolyte balance, medication interactions, and underlying heart conditions can all matter.
- 11:44[SPEAKER_01]: And I begin session without rigorous screening, qualified medical staff, continuous monitoring, and a real emergency plan can be deadly.
- 11:53[SPEAKER_01]: No testimonial, however moving, is a substitute for those protections.
- 11:58[SPEAKER_01]: This is also why the phrase, natural medicine can be misleading.
- 12:02[SPEAKER_01]: Natural does not mean harmless.
- 12:05[SPEAKER_01]: Plants contain active chemicals.
- 12:07[SPEAKER_01]: Supplements can interact with prescription drugs.
- 12:10[SPEAKER_01]: A substance may be sacred, traditional, natural.
- 12:14[SPEAKER_01]: and still medically dangerous for a particular person.
- 12:17[SPEAKER_01]: People with certain hard conditions by polar disorder, psychotic disorders, or complex medical regimens, may face heightened risks from psychedelic treatments.
- 12:28[SPEAKER_01]: No one should abruptly stop anti-depressants, Parkinson's medications, or any other prescription in order to participate in a ceremony or retreat.
- 12:38[SPEAKER_01]: Medication changes require qualified medical guidance.
- 12:42[SPEAKER_01]: There is another danger, and altered state can make a person physically vulnerable and unusually suggestible.
- 12:49[SPEAKER_01]: Anyone considering a facilitator, clinic, retreat, or so-called church should ask direct questions.
- 12:57[SPEAKER_01]: What training does the staff have is their medical screening, who supplies and tests the substances?
- 13:04[SPEAKER_01]: what is the touch policy our sessions recorded can consent be withdrawn at any moment is there a licensed clinician present what emergency equipment is available what happens after the session are their independent references and a clear way to report misconduct legality is not proof of competence
- 13:26[SPEAKER_01]: illegality is not proof of the incompetence.
- 13:29[SPEAKER_01]: A religious designation is not proof of safety.
- 13:32[SPEAKER_01]: A white coat is not proof of wisdom.
- 13:35[SPEAKER_01]: The work is to look past appearances and examine the actual safeguards.
- 13:40[SPEAKER_01]: The same caution applies to products sold online in smoke shops or at gas stations as magic mushrooms, gummies or chocolates.
- 13:50[SPEAKER_01]: Packaging can be polished while the contents are mislabeled, contaminated, or entirely different from what a buyer expects.
- 13:57[SPEAKER_01]: Street drug sold as MDMA, ketamine, or another psychedelic may contain fentanyl or other dangerous adulterants.
- 14:05[SPEAKER_01]: The safest assumption is that an unregulated product has an unknown identity and an unknown dose.
- 14:11[SPEAKER_01]: What about microdosing?
- 14:13[SPEAKER_01]: Microdosing generally means taking a small, sub-perceptual amount of a psychedelic, often, psilocybin or LSD, with the hope of improving mood, focus, or creativity without producing a full psychedelic experience.
- 14:27[SPEAKER_01]: popular enthusiasm is moved faster than the evidence.
- 14:31[SPEAKER_01]: Some people report subtle benefits, control studies have produced mixed results, and expectancy or placebo effects may explain at least part of what users experience.
- 14:41[SPEAKER_01]: Questions about dose, frequency, product consistency, drug interactions, and long-term safety remain open.
- 14:50[SPEAKER_01]: Small dose does not mean risk-free, and taking a psychedelic every day can build tolerance.
- 14:56[SPEAKER_01]: The responsible position is neither automatic to spiss on nor automatic belief.
- 15:01[SPEAKER_01]: It is curiosity with standards.
- 15:03[SPEAKER_01]: That may be the central tension in psychedelic medicine today.
- 15:07[SPEAKER_01]: On one side is a medical system that can be slow, expensive, fragmented, and too focused on symptom management.
- 15:16[SPEAKER_01]: And on the other, is a rapidly growing psychedelic marketplace that can turn hope into hype before evidence and safeguards catch up.
- 15:24[SPEAKER_01]: We need research.
- 15:25[SPEAKER_01]: But we also need humility.
- 15:27[SPEAKER_01]: We need pharmaceutical development that can produce consistent dosing, reduced known risks, and expand access.
- 15:35[SPEAKER_01]: We also need protections against monopoly, exploitation, and the erasure of indigenous knowledge.
- 15:41[SPEAKER_01]: We need clinicians who understand drug interactions, and psychiatric risk.
- 15:46[SPEAKER_01]: We need ethical facilitators, trained integration support and policies that do not reserve emerging treatments only for wealthy people and we need language that leaves room for both possibility and uncertainty.
- 16:00[SPEAKER_01]: Lisa's own route into this work was not direct.
- 16:04[SPEAKER_01]: She studied mathematical economics, worked in investment banking, later studied psychology and worked with children who had experienced sexual abuse as well as adults who had committed abuse.
- 16:15[SPEAKER_01]: She saw how untreated trauma could echo across generations.
- 16:20[SPEAKER_01]: Years later, working cannabis education, letter towards psychedelic research and advocacy.
- 16:26[SPEAKER_01]: What drew her in was the possibility that entrenched cycles might not be permanent.
- 16:32[SPEAKER_01]: Lisa told me that she began to think maybe we can interrupt the pattern.
- 16:38[SPEAKER_01]: Maybe people do not have to stay trapped in the same pain forever.
- 16:42[SPEAKER_02]: Eye-beginne has been shown to interrupt chronic pain, and still a siphon is being shown.
- 16:49[SPEAKER_01]: Physical pain.
- 16:51[SPEAKER_02]: Yes, because the neuroplasticity, you know, because not of the pain.
- 16:54[SPEAKER_02]: It's like, I don't know if you're familiar with the term phantom limb pain, but some, yeah.
- 16:58[SPEAKER_02]: Okay, someone who loses a limb for years can feel like that arm or the leg or the hand is still there.
- 17:04[SPEAKER_02]: So,
- 17:05[SPEAKER_02]: Psychedelic medicines have been said to support that.
- 17:09[SPEAKER_01]: She has spoken with hundreds of people who believe these medicines help them heal.
- 17:14[SPEAKER_01]: That does not mean every medicine works for every person.
- 17:17[SPEAKER_01]: It means the possibility to deserve serious attention and serious study.
- 17:22[SPEAKER_01]: And that is a ground to place to end.
- 17:24[SPEAKER_01]: Not with a miracle cure and not with fear.
- 17:27[SPEAKER_01]: Psychedelic therapy may become an important part of how we treat trauma, depression, addiction, and existential distress.
- 17:36[SPEAKER_01]: but the medicine is only one element.
- 17:38[SPEAKER_01]: Healing also lives in preparation, relationship, ethics, integration, community, and time.
- 17:46[SPEAKER_01]: Perhaps the greatest promise of these therapies is not that they will save humanity in a single revelation.
- 17:52[SPEAKER_01]: It is that they may help some people discover a little bit more freedom inside their own minds.
- 17:59[SPEAKER_01]: and with support, practice that freedom in the lives they return to.
- 18:03[SPEAKER_01]: If you are interested in participating in legitimate research, visit clinicaltrials.gov that's clinicaltrialsall1mord.gov and discuss the study with a qualified medical professional.
- 18:16[SPEAKER_01]: If you, or someone you know, is an immediate danger or experiencing an mental health crisis in the United States, call or text 988.
- 18:26[SPEAKER_01]: This program is for education only, it is not medical advice and does not encourage a legal drug use.
- 18:32[SPEAKER_01]: Never stop a prescribed medication or undertake psychedelic treatment without appropriate medical guidance.
- 18:38[SPEAKER_01]: My conversation with Lisa Solomon goes much deeper into these questions, including preparation, integration, eye-begining, ketamine, microdosing, and the changing political landscape around psychedelic medicine.
- 18:52[SPEAKER_01]: You'll find the complete interview linked with this video in the show notes down below.
- 18:56[SPEAKER_01]: This program is a companion piece to my full conversation with Lisa Solomon, episode 37 of the Rhythm of Life podcast, the trauma breakthrough that is changing lives.
- 19:07[SPEAKER_01]: If you're watching on YouTube, you can find that conversation in the rhythm of life playlist on the vital circuit channel.
- 19:14[SPEAKER_01]: If you're listening on a podcast platform, it's episode 37.
- 19:18[SPEAKER_01]: The episode immediately preceding this one.
- 19:20[SPEAKER_01]: Lisa and I go much deeper into preparation, integration, eye-beginne, ketamine, micro-dosing, and the changing landscape of psychedelic medicine.
- 19:29[SPEAKER_01]: And coming up next on both vital circuit and the rhythm of life podcast, we turn from psychedelic medicine to another emerging approach to healing, red light therapy.
- 19:38[SPEAKER_01]: It has become one of the most talked about tools and modern recovery, but what can it actually do?
- 19:43[SPEAKER_01]: We'll examine the science of photo biomodulation, with the evidence appears promising and how to separate legitimate benefits from some very expensive red colored height.
- 19:57[SPEAKER_01]: Our editor is Adam Shakur and our social media manager and graphic artist for Rhythm and Light is Carrey Tanner.
- 20:03[SPEAKER_01]: If you found this program valuable, please like and share it and subscribe to Vital Circuit on YouTube.
- 20:09[SPEAKER_01]: You can also follow Vital Circuit on Instagram and Facebook and find more original programs and conversations from Rhythm and Light on YouTube, Instagram and Facebook.
- 20:19[SPEAKER_01]: Thank you so much for joining us.
- 20:21[SPEAKER_01]: I'm Steve Wardoward and this is Rhythm of Life.
- 20:25[SPEAKER_01]: and vital circuit.
- 20:26[SPEAKER_01]: Thank you for watching.
- 20:28[SPEAKER_00]: This has been a rhythm and light production.